Insider Trading June 5, 2026 06:56 PM

Ichor Holdings CEO Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan

Philip Ryan Barros Sr. liquidates 13,705 shares for $961,953 as stock approaches overvalued territory per fair value metrics

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
ICHR

Philip Ryan Barros Sr., Chief Executive Officer of Ichor Holdings, Ltd. (NASDAQ: ICHR), executed a significant divestment of company stock on June 4, 2026, selling 13,705 ordinary shares for a total of $961,953. The transactions were facilitated through a Rule 10b5-1 trading plan established earlier in the year, with the shares sold at prices ranging from $68.51 to $72.22 per share, averaging $70.19. This sale occurs against a backdrop of substantial price appreciation and recent positive financial results, while fair value analysis suggests the stock may be trading above its intrinsic worth.

Ichor Holdings CEO Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan
ICHR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Philip Ryan Barros Sr. sold 13,705 shares for $961,953 under a Rule 10b5-1 plan, with the stock up 258% over the past year but currently showing signs of overvaluation.
  • The semiconductor and related devices sector sees continued analyst optimism, as evidenced by Needham raising its price target to $72 following strong Q1 2026 earnings that beat expectations.
  • Stock volatility remains a key consideration, with a beta of 1.88 indicating significant price swings, while the company maintains strong shareholder support with all director nominees re-elected at the 2026 Annual General Meeting.

Philip Ryan Barros Sr., the Chief Executive Officer of Ichor Holdings, Ltd. (NASDAQ: ICHR), has completed the sale of 13,705 ordinary shares on June 4, 2026, netting $961,953 from the transaction. The divestment was executed under the parameters of a Rule 10b5-1 trading plan that Mr. Barros established on March 5, 2026. The shares were disposed of at a weighted average price of $70.19, with individual trade prices fluctuating between $68.51 and $72.22 per share.

Mr. Barros's sale activity follows a period of significant price appreciation for Ichor Holdings, with the stock delivering a 258% return over the trailing twelve months. Despite this strong performance, fair value analysis from InvestingPro indicates that the current share price may be elevated relative to intrinsic value. The analysis also highlights substantial price volatility, noting a beta of 1.88, which suggests that the stock's movements are more pronounced than the broader market average.

In a concurrent transaction, Mr. Barros acquired 1,403 ordinary shares by exercising stock options. These shares were obtained at an exercise price of $21.76 per share, resulting in a total cost of $30,529. The options exercised were subject to a vesting schedule that commenced with 25% vesting on May 12, 2021, with the remaining shares vesting ratably on a quarterly basis over the following three-year period. Following these transactions, Mr. Barros directly holds 165,078 ordinary shares in Ichor Holdings, Ltd. He continues to serve in his dual capacity as both a director and the Chief Executive Officer of the semiconductor and related devices manufacturer.

Recent corporate developments have underscored positive momentum for Ichor Holdings. The company reported robust first-quarter 2026 financial results that surpassed analyst expectations. Revenue reached $256.1 million, exceeding the projected $235.59 million, while earnings per share (EPS) came in at $0.15, significantly beating the forecasted $0.06. In response to these results, Needham raised its price target for Ichor Holdings to $72 from $48, while maintaining a Buy rating.

Additionally, the company held its 2026 Annual General Meeting of Shareholders, where all director nominees were elected to serve until the 2027 meeting. The meeting recorded a total of 30,596,247 outstanding ordinary shares represented by proxy. Each director nominee received more votes in favor than against, securing their positions. These developments highlight a period of positive momentum for Ichor Holdings.

Investors interested in further analysis can access 11 additional ProTips and comprehensive Pro Research Reports covering ICHR and over 1,400 US equities.

Risks

  • Fair value analysis suggests the stock may be overvalued relative to its intrinsic worth, posing a risk to investors who may be buying at peak prices despite recent strong performance.
  • The high beta of 1.88 indicates elevated volatility, which could lead to sharp price declines in the semiconductor and related devices sector if market conditions shift or if broader tech valuations correct.
  • While recent earnings beat expectations, the reliance on a Rule 10b5-1 plan for the CEO's sale limits insight into insider sentiment, leaving investors to interpret the transaction within the context of pre-arranged trading protocols rather than discretionary decisions.

More from Insider Trading

Personalis Executive Activity and Strategic Developments Jun 5, 2026 Hinge Health Chairman Executes $3.28 Million Share Sale Amid Strong Quarterly Results Jun 5, 2026 Grail Executive Disposes of Shares Amidst Mixed Clinical and Financial Developments Jun 5, 2026 Global Graphene Group Disposes of $3.69M Solidion Technology Stake Amid Patent and Financing Developments Jun 5, 2026 MP Materials CEO Executes $12.8M Stock Sale Amid Valuation Debate Jun 5, 2026